van der Schaft DW - Search Results

1

Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.

Mayo KH, van der Schaft DW, Griffioen AW. Mayo KH, et al. Among authors: van der schaft dw. Angiogenesis. 2001;4(1):45-51. doi: 10.1023/a:1016672117477. Angiogenesis. 2001. PMID: 11824378

2

Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.

Mayo KH, Dings RP, Flader C, Nesmelova I, Hargittai B, van der Schaft DW, van Eijk LI, Walek D, Haseman J, Hoye TR, Griffioen AW. Mayo KH, et al. Among authors: van der schaft dw, van eijk li. J Biol Chem. 2003 Nov 14;278(46):45746-52. doi: 10.1074/jbc.M308608200. Epub 2003 Aug 28. J Biol Chem. 2003. PMID: 12947097 Free article.

3

The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI).

van der Schaft DW, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Ann Med. 2002;34(1):19-27. doi: 10.1080/078538902317338607. Ann Med. 2002. PMID: 12014429 Review.

4

Anti-tumor activity of the novel angiogenesis inhibitor anginex.

Dings RP, van der Schaft DW, Hargittai B, Haseman J, Griffioen AW, Mayo KH. Dings RP, et al. Among authors: van der schaft dw. Cancer Lett. 2003 May 8;194(1):55-66. doi: 10.1016/s0304-3835(03)00015-6. Cancer Lett. 2003. PMID: 12706859

5

Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells.

van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW. van der Schaft DW, et al. Blood. 2000 Jul 1;96(1):176-81. Blood. 2000. PMID: 10891448 Free article.

6

Anginex, a designed peptide that inhibits angiogenesis.

Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF, Mayo KH. Griffioen AW, et al. Among authors: van der schaft dw. Biochem J. 2001 Mar 1;354(Pt 2):233-42. doi: 10.1042/0264-6021:3540233. Biochem J. 2001. PMID: 11171099 Free PMC article.

7

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: van eijk li. FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397082

8

Effect of culture conditions on endothelial cell growth and responsiveness.

Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW. Relou IA, et al. Among authors: van der schaft dw. Tissue Cell. 1998 Oct;30(5):525-30. doi: 10.1016/s0040-8166(98)80032-3. Tissue Cell. 1998. PMID: 9839475

9

Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity.

Ahmed B, Van Eijk LI, Bouma-Ter Steege JC, Van Der Schaft DW, Van Esch AM, Joosten-Achjanie SR, Lambin P, Landuyt W, Griffioen AW. Ahmed B, et al. Among authors: van esch am, van eijk li, van der schaft dw. Int J Cancer. 2003 May 20;105(1):20-5. doi: 10.1002/ijc.11010. Int J Cancer. 2003. PMID: 12672025 Free article.

10

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW. Dirkx AE, et al. Among authors: van der schaft dw. FASEB J. 2006 Apr;20(6):621-30. doi: 10.1096/fj.05-4493com. FASEB J. 2006. PMID: 16581970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page